New therapeutic approaches for equine protozoal myeloencephalitis: Pharmacokinetics of diclazuril sodium salts in horses

Veterinary Therapeutics

Volumn 7, Issue 1, 2006, Pages

  Dirikolu, Levent ^a   Karpiesiuk, Wojciech ^a   Lehner, Andreas F ^b   Hughes, Charlie ^a   Woods, William E ^a   Harkins, John D ^a   Boyles, Jeff ^a   Atkinson, Alfonza ^c   Granstrom, David E ^d   Tobin, Thomas ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c TUSKEGEE UNIVERSITY   (United States)

^d AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCCIDIOSTATIC AGENT; DICLAZURIL; DIMETHYL SULFOXIDE; INORGANIC SALT; NITRILE; SODIUM; TRIAZINE DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOAVAILABILITY; BLOOD; CENTRAL NERVOUS SYSTEM INFECTION; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HORSE; HORSE DISEASE; METABOLISM; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CENTRAL NERVOUS SYSTEM PROTOZOAL INFECTIONS; CHEMISTRY, PHARMACEUTICAL; COCCIDIOSTATS; DIMETHYL SULFOXIDE; FEMALE; HORSE DISEASES; HORSES; NITRILES; SALTS; SODIUM; TRIAZINES;

EQUIDAE; EQUUS CABALLUS;

EID: 33645941800     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Rooney JR, Prickett ME, Delaney FM: Focal myelitis-encephalitis in horses. Cornell Vet 60:494-501, 1970.
2. Prickett ME: Equine spinal ataxia. Proc AAEP 14:147, 1968.
3. Dubey JP, Dawis SW, Speer CA, et A Sarcocystis neurona n. sp. (Protozoa-Apicomplexa), the etiologic agent of equine protozoal myeloencephalitis. J Parasitol 77:212, 1991.
4. Daft BM, Barr BC, Collins N, Sverlow KW. Neospora encephalomyelitis and polyradiculoneuritis in an aged mare with Cushing's disease. Equine Vet J 29: 240-243, 1997.
5. Marsh AE, Howe DK, Wang G, et al: Differentiation of Neospora hughesi from Neospora caninum based on their immunodominant surface antigens, SAG1 and SRS2. Int J Parasitol 29(10):l575-1582, 1999.
6. Granstrom ED, McCrillis S, Wulff-Strobel C, et al: A clinical report of diclazuril treatment for equine protozoal myeloencephalitis [abstract]. Proc AAEP 43:3-14, 1997.
7. Rossano MG, Kaneene JB, Marteniuk JV, et al:The seroprevalence of antibodies to Sarcocystis neurona in Michigan equids. Prevent Vet Med 48(2):113-128, 2001.
8. Welsch BB: Treatment of equine protozoal myeloencephalitis. Compend Contin Educ Pract Vet 13(10): 1599-1602, 1991.
9. Clarke CR, MacAllister CG, Spillers DK, Burrows SL: Pharmacokinetics, penetration into cerebrospinal fluid, and hematologic effects after multiple oral administrations of pyrimethamine to horses. Am J Vet Res 53(12):2296-2299, 1992.
10. Bentz BG, Granstrom ED, Tobin T, et al: Preliminary report on diclazuril and equine protozoal myeloencephalitis [abstract]. Proc 8th Int Conf Equine Infect Dis:168, 1998.
11. Dirikolu L, Woods WE, Carter W, et al: Diclazuril in the horse: Its identification, detection and preliminary pharmacokinetics. J Vet Pharmacol Ther 22:374-379, 1999.
12. Miller JC, Miller JN: Statistics for Analytical Chemistry. New York, John Wiley, 1984.
13. Kock DJ, Smet DM, Sneyers R: Determination of diclazuril in animal feed by liquid chromatography. J Chromatog 606(1):141-146, 1992.
14. Gibaldi M, Perrier D: Pharmacokinetics, ed 2. New York, Marcel Dekker, 1982, pp 409-417.
15. Houston JB, Upshall DG, Bridges JW. A re-evaluation of the importance of partition coefficients in the gastrointestinal absorption of nutrients. J Pharmacol Exp Therap 189:244-254, 1974.